DP
ARKG icon

DDD Partners’s ARK Genomic Revolution ETF ARKG Stock Holding History

DDD Partners’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$681K Sell
16,183
-689
-4% -$21.9K 0.04% 92
2026
Q1 		$446K Sell
16,872
-1,261
-7% -$36.9K 0.03% 102
2025
Q4 		$525K Sell
18,133
-17,706
-49% -$531K 0.03% 93
2025
Q3 		$995K Sell
35,839
-303
-0.8% -$7.66K 0.06% 77
2025
Q2 		$880K Buy
36,142
+401
+1% +$8.79K 0.09% 64
2025
Q1 		$742K Buy
35,741
+7,294
+26% +$183K 0.09% 62
2024
Q4 		$670K Sell
28,447
-126,370
-82% -$3.11M 0.08% 63
2024
Q3 		$3.96M Sell
154,817
-2,113
-1% -$53.8K 0.43% 40
2024
Q2 		$3.68M Sell
156,930
-2,342
-1% -$59.1K 0.43% 42
2024
Q1 		$4.58M Sell
159,272
-2,456
-2% -$73.9K 0.56% 39
2023
Q4 		$5.31M Sell
161,728
-2,744
-2% -$74.6K 0.71% 38
2023
Q3 		$4.12M Sell
164,472
-17,170
-9% -$561K 0.59% 39
2023
Q2 		$6.19M Buy
181,642
+605
+0.3% +$19K 0.86% 38
2023
Q1 		$5.44M Sell
181,037
-3,250
-2% -$101K 0.85% 37
2022
Q4 		$5.2M Buy
184,287
+1,332
+0.7% +$42.3K 0.83% 33
2022
Q3 		$6.01M Buy
182,955
+1,838
+1% +$67.5K 1.09% 33
2022
Q2 		$5.7M Buy
+181,117
New +$6.33M 0.99% 29

Other funds holding ARKG

JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
JFG
Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

DDD Partners's ARKG Position: Q2 2026 in Review

DDD Partners reduced its ARK Genomic Revolution ETF (ARKG) stake by 4.1% in Q2 2026, selling an estimated $21.9K and leaving 16,183 shares worth $681K. The position accounts for 0.04% of the portfolio, ranked #92.

DDD Partners first reported a position in ARKG in Q2 2022 and has held it in 17 quarters since. The position peaked at $6.19M in Q2 2023. 272 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.

  • DDD Partners held 16,183 shares of ARK Genomic Revolution ETF worth $681K as of Q2 2026.
  • DDD Partners sold 689 ARK Genomic Revolution ETF shares in Q2 2026, an estimated $21.9K.
  • ARK Genomic Revolution ETF made up 0.04% of DDD Partners's portfolio in Q2 2026, its #92 holding.
  • DDD Partners first reported a position in ARK Genomic Revolution ETF in Q2 2022 and has held it in 17 quarters since.
  • DDD Partners's ARK Genomic Revolution ETF position peaked at $6.19M in Q2 2023.
  • 272 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.

Based on DDD Partners's 13F filing for Q2 2026, filed 5 Aug 2026.